1 Min Read
NEW YORK, Dec 16 (Reuters) - Agenus Inc : * Up 27.5 percent to $3.11 in premarket after phase 2 results for brain cancer vaccine
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.